LOCOREGIONAL RECURRENCE OF BREAST CANCER AFTER RADICAL MASTECTOMY: RISK FACTORS, DIAGNOSIS, AND REGIONAL MANAGEMENT STRATEGIES

FULL TEXT:

Abstract

Relevance. Locoregional recurrence (LRR) of breast cancer (BC) following radical mastectomy presents a significant clinical challenge and is associated with reduced survival. Objective. To assess the risk factors for LRR and develop regional recommendations for effective surveillance and treatment strategies. Materials and methods of the study. A retrospective-prospective analysis of 206 breast cancer patients treated between 2017 and 2024 in the Samarkand region was conducted. The study focused on tumor characteristics, molecular profiles, treatment modalities, recurrence localization, and survival outcomes. Research results. The LRR rate was 5.4%. Most recurrences occurred in women aged 31–50 and in patients with stage IIB–IIIA tumors. Hormone receptor status, HER2 expression, Ki-67 index, and completeness of adjuvant therapy were significant predictors of recurrence. The proposed management algorithm, based on molecular stratification and regional resources, demonstrated potential for improving long-term outcomes. Conclusion. Personalized follow-up and therapy plans based on tumor biology and regional guidelines are essential for reducing recurrence and improving survival in postmastectomy breast cancer patients.

About the Authors

List of references

Djurayev MD, Uzokov SM, Kutlumuratov AB, Esankulova BS. To the question of the risk of poctmastectomic lymphedema in patients with breast cancer and its connection with concomitant vascular pathology. Science and Innovation. 2023 Oct 31;2(10). doi:10.5281/zenodo.10057478.

Djurayev MD, Uzokov SM, Kutlumuratov AB, Esankulova BS. Whether exist links between toxic injury and risk of poctmastectomic lymphedema in breast cancer patients? Science and Innovation. 2023 Oct;2(10). UIF-2022: 8.2. Available from: https://scientists.uz

Eiermann W, Peapke D, Appfelstaedt J, et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter trial. Ann Oncol. 2001;12:1527–1532.

Elkhuizen PH, van Slooten HJ, Clahsen PC, et al. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. J Clin Oncol. 2000;18:1075–1083.

National Center for Biotechnology Information (NCBI). Entrez Gene: ERBB2 v-erb-b2 erythroblastic leukemia viral oncogene homolog 2. Available from: https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2064

Ferguson CM, Swaroop MN, Horick N, et al. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol. 2016;34:691–698.

Улмасов ФГ, Джураев МД, Эсанкулова БС, Ортикова ХУ. Значение комбинированных и мультивисцеральных резекций при лечении злокачественных опухолей в забрюшинном пространстве. Eurasian Journal of Oncology. 2024;12(2):214–220. doi:10.34883/PI.2024.12.2.026.

How to Cite

1.
Djurayev M, Zaripova P. LOCOREGIONAL RECURRENCE OF BREAST CANCER AFTER RADICAL MASTECTOMY: RISK FACTORS, DIAGNOSIS, AND REGIONAL MANAGEMENT STRATEGIES. MSU [Internet]. 2025 Jun. 28 [cited 2025 Jun. 29];(3):09-13. Available from: https://fdoctors.uz/index.php/journal/article/view/148
Views: 1